SRNE News and Press, Sorrento Therapeutics Inc. From 08/19/20

After the market closed on Tuesday, Sorrento Therapeutics (NASDAQ: SRNE) disclosed in an SEC filing that it fired Executive Vice President and Chief Financial Officer Jiong Shao, effective immediately. Shares of the stock down around 11.7% at 1:29 pm on Wednesday. Najjam Asghar, formerly So...

Sorrento Therapeutics ( SRNE -9.3% ) is filing an IND application for COVI-GUARD (STI-1499) for hospitalized COVID-19 patients today. More news on: Sorrento Therapeutics, Inc., Healthcare stocks news, Read more ...

IND filing today for STI-1499 (COVI-GUARD™) for hospitalized COVID-19 patients. The initial trial is expected to be followed by pivotal trials with a goal of potentially receiving an EUA (Emergency Use Authorization) as early as the end of this year. Animal model data (Syrian Gol...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . S&P 500 to take aim at new record The S&P 500 is looking to hit a new record with stimulus in focus and the Fed keeping rate...

Jiong Shao is out of the chief financial officer's role at Sorrento Therapeutics (NASDAQ: SRNE ) , according to a company filing. More news on: Sorrento Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...

MICT (NASDAQ: MICT ) +95%  on first major order for SmartCam. More news on: MICT, Inc., Forward Industries, Inc., iMedia Brands, Inc., Stocks on the move, , Read more ...

San Diego based Sorrento Therapeutics ( SRNE ) is a clinical stage and commercial biopharma company . The Company operates through two segments: Sorrento Therapeutics and Scilex. The Sorrento Therapeutics segment is organized around its Immune-Oncology therapeutic area, leveraging its G-MAB...

Groundbreaking. Game-changer. Those are the kinds of words being used to describe SalivaDirect, a COVID-19 diagnostic test developed by the Yale School of Public Health. The U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization to SalivaDirect on Aug. 15, 2020.  Saliv...

Shares of  Sorrento Therapeutics (NASDAQ: SRNE) declined on Monday after a new competing saliva-based COVID-19 test received emergency use authorization from the Food and Drug Administration. By the close of trading, Sorrento's stock was down 3% after falling as much as 18% earlier in th...

Unity Biotechnology (NASDAQ: UBX )   -51%  on stumble with lead drug . More news on: Unity Biotechnology, Inc., Interpace Biosciences, Inc., Taiwan Liposome Company, Ltd., Stocks on the move, , Read more ...